CD3 binding antibodies
MYPI2025008119A0Undetermined Publication Date: 2018-03-14TENEOONE INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025008119
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2017-04-28
- Filing Date
- 2017-06-20
- Publication Date
- 2018-03-14
Abstract
ABSTRACT CD3 BINDING ANTIBODIES There is disclosed one or more polynucleotides encoding a bispecific antibody, wherein the bispecific antibody comprises: (a) a first binding moiety specific for human CD3δɛ, wherein the first binding moiety comprises: (i) a first polypeptide subunit comprising a heavy chain variable (VH) domain comprising a CDR1 having an amino acid sequence of GFTFDDYA (SEQ ID NO:29), a CDR2 having an amino acid sequence of ISWNSGSI (SEQ ID NO:24), and a CDR3 having an amino acid sequence of AKDSRGYGDYRLGGAY (SEQ ID NO:41); and (ii) a second polypeptide subunit comprising a light chain variable (VL) domain comprising a CDR1 having an amino acid sequence of QSVSSN (SEQ ID NO:35), a CDR2 having an amino acid sequence of GAS (SEQ ID NO:38), and a CDR3 having an amino acid sequence of QQYNNWPWT (SEQ ID NO:45); and (b) a second binding moiety specific for human BCMA, wherein the second binding moiety comprises: (i) a third polypeptide subunit comprising a VH domain comprising a CDR1 having an amino acid sequence of GFTVSSYG (SEQ ID NO:36), a CDR2 having an amino acid sequence of IRGSDGST (SEQ ID NO:39), and a CDR3 having an amino acid sequence of AKQGENDGPFDH (SEQ ID NO:46). FIG. 1
Need to check novelty before this filing date? Find Prior Art
